Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Formulated hexane fraction of Costus afer leaves balm suppressed xylene induced topical inflammation in rat model

Godswill Nduka Anyasor, Olamidotun Henry Ijituyi.




Abstract

Objective: This study was designed to evaluate the effects of topically applied hexane fraction and aqueous extract of C. afer leaves balm and cream formula on xylene-induced ear edema.
Methods: In vitro anti-inflammatory study was carried out using thermally-induced protein denaturation and human erythrocyte membrane stabilization assays while in vivo anti-inflammatory study was performed using xylene-induced ear edema in rat model.
Results: Hexane fraction of C. afer leaves significantly inhibited thermally-induced protein denaturation and stabilized human erythrocyte membrane against hypotonicity-induced hemolysis when compared with aqueous extract of C. afer leaves. Furthermore, in vivo study showed that 10% and 20% w/w hexane fraction of C. afer leaves balm formula at 360 min significantly suppressed xylene-induced ear edema by 82.02% (0.16 ± 0.01 mm) and 96.62% (0.03 ± 0.01 mm) respectively when compared with 10% and 20% w/w aqueous extract of C. afer leaves cream formula with 55.06% (0.40 ± 0.01 mm) and 67.42% (0.29 ± 0.02 mm) inhibitions respectively.
Conclusion: The findings from this study revealed that hexane fraction of C. afer leaves balm formula exhibited higher anti-inflammatory activity against xylene-induced topical inflammation.

Key words: Anti-inflammation; balm; cream; Costus afer; topical inflammation






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.